IA
NVO

Icon Advisers’s Novo Nordisk NVO Stock Holding History

Icon Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-23,000
Closed -$412K – 417
2016
Q4 		$412K Sell
23,000
-33,200
-59% -$602K 0.03% 371
2016
Q3 		$1.17M Buy
+56,200
New +$1.39M 0.08% 279
2015
Q1 		– Sell
-243,000
Closed -$5.14M – 352
2014
Q4 		$5.14M Buy
+243,000
New +$5.43M 0.31% 101
2014
Q1 		– Sell
-63,000
Closed -$1.16M – 338
2013
Q4 		$1.16M Sell
63,000
-163,210
-72% -$2.84M 0.08% 169
2013
Q3 		$3.83M Hold
226,210
– – 0.29% 87
2013
Q2 		$3.51M Buy
+226,210
New +$3.77M 0.27% 95

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Icon Advisers's NVO Position: Q1 2017 in Review

Icon Advisers sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 23,000 shares — an estimated $412K sold.

Icon Advisers first reported a position in NVO in Q2 2013 and held it in 6 quarters. The position peaked at $5.14M in Q4 2014. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Icon Advisers reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Icon Advisers sold 23,000 Novo Nordisk shares in Q1 2017, an estimated $412K.
  • Icon Advisers first reported a position in Novo Nordisk in Q2 2013 and held it in 6 quarters.
  • Icon Advisers's Novo Nordisk position peaked at $5.14M in Q4 2014.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Icon Advisers's 13F filing for Q1 2017, filed 4 May 2017.